Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0000313143-26-000155

VP, Chief Accounting Officer sold 836 shares at $120.99 ($101,148)

  • VP, Chief Accounting Officer gave up 1,724 shares (to pay taxes)
  • VP, Chief Accounting Officer acquired 2,146 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Maunsell Farris Maryanne · VP, Chief Accounting Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-11 Exercise or conversion : show line 1 in the form +1,068 $89.16 $95,223 7,310 D
2026-11-11 Exercise or conversion : show line 2 in the form +645 $95.73 $61,746 7,955 D
2026-11-11 Exercise or conversion : show line 3 in the form +433 $70.31 $30,444 8,388 D
2026-11-11 Shares withheld for taxes : show line 4 in the form −1,724 $121.10 $208,776 6,664 D
2026-11-11 Sale : show line 5 in the form −836 $120.99 $101,148 5,828 D
Open-market sales · 836 sh · avg $120.99 · $101,148

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-11-11 Exercise or conversion : show line 6 in the form Non-qualified Stock Option (Right to Buy) −1,068 357 D
2026-11-11 Exercise or conversion : show line 7 in the form Non-qualified Stock Option (Right to Buy) −645 646 D
2026-11-11 Exercise or conversion : show line 8 in the form Non-qualified Stock Option (Right to Buy) −433 1,299 D
Loading xslF345X06/form4.xml…